Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia (DigiLipids)

Karolinska Institute

Status: Invitation-only

Conditions: Hypercholesterolemia; Familial Hypercholesterolemia

Study type: Observational

Funder types: Other

Identifiers

NCT04929457

DigiLipids

Details and patient eligibility

About

Longitudinal and observational registry-based cohort study of individuals participating in the national digiphysical screening program for Familial Hypercholesterolemia. The information collected in the screening process will be combined in pseudo-anonymous form with data from the National Board of Health and Welfare (registries: Cause of Death, Diagnoses according to International Classification of Diseases (ICD) and Prescribed drugs) and Statistic Sweden (Longitudinal integrated database for health insurance and labour market studies). Primary analysis: association between Familial Hypercholesterolemia and cardiovascular disease. Secondary analysis: efficacy and health economic aspects of digiphysical screening for Familial Hypercholesterolemia.

Enrollment: 30,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Swedish personal identification number

Exclusion criteria

• Decline informed consent

Trial design

30,000 participants in 1 patient group

Individuals screened for Familial Hypercholesterolemia

Description:

Individuals participating in diagnostic activities in the digiphysical health care screening program for Familial Hypercholesterolemia and have provided informed consent are included in the cohort.